IP Verse

Novel Tnf Structure For Use In Therapy - EP3311168B1

PatentPatent Analysis

EP3311168

UCB BIOPHARMA
Application Number
EP15784067A
Filing Date
Oct 22, 2015
Status
Granted And Under Opposition
Apr 7, 2023
Grant Date
May 10, 2023
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3630946B1
EP3717631B1
EP2515887B1

Bibliography

The patent EP3311168B1 was granted to UCB Biopharma on May 10, 2023 following the initial filing on Oct 22, 2015 under the application number EP15784067A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

DR H ULRICH DORRIESFeb 12, 2024ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents